Variant report

Variant	esv3357520
Chromosome Location	chr3:46939998-46942796
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:40)
CpG islands
(count:366)
Chromatin interactive
region (count:10)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:40 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr3:46940112-46940311	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr3:46940205-46940289	GM12892	blood:	n/a	n/a
3	CTCF	chr3:46940156-46940243	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr3:46940267-46940365	H1-hESC	embryonic stem cell:	n/a	n/a
5	CTCF	chr3:46940205-46940357	GM12891	blood:	n/a	n/a
6	CTCF	chr3:46940239-46940259	GM19238	blood:	n/a	n/a
7	CTCF	chr3:46940243-46940342	GM19239	blood:	n/a	n/a
8	EP300	chr3:46941219-46941918	ECC-1	luminal epithelium:	n/a	n/a
9	EP300	chr3:46941397-46941657	SK-N-SH_RA	brain:	n/a	n/a
10	EP300	chr3:46941397-46941643	SK-N-SH_RA	brain:	n/a	n/a
11	EP300	chr3:46941094-46941835	SK-N-SH	brain:	n/a	n/a
12	ESR1	chr3:46941370-46941649	ECC-1	luminal epithelium:	n/a	n/a
13	GABPA	chr3:46940064-46940441	H1-hESC	embryonic stem cell:	n/a	n/a
14	HMGN3	chr3:46940154-46940257	K562	blood:	n/a	n/a
15	HMGN3	chr3:46941365-46941711	K562	blood:	n/a	n/a
16	JUND	chr3:46940212-46940242	H1-hESC	embryonic stem cell:	n/a	n/a
17	MAX	chr3:46939980-46940624	H1-hESC	embryonic stem cell:	n/a	n/a
18	MAX	chr3:46939977-46940579	H1-hESC	embryonic stem cell:	n/a	n/a
19	MXI1	chr3:46941238-46941984	SK-N-SH	brain:	n/a	n/a
20	MYC	chr3:46940604-46940693	H1-hESC	embryonic stem cell:	n/a	n/a
21	NFIC	chr3:46941171-46941854	ECC-1	luminal epithelium:	n/a	n/a
22	NFIC	chr3:46941181-46941875	ECC-1	luminal epithelium:	n/a	n/a
23	PAX5	chr3:46940116-46940327	GM12878	blood:	n/a	n/a
24	PAX5	chr3:46940161-46940324	GM12878	blood:	n/a	n/a
25	PAX5	chr3:46940099-46940385	GM12892	blood:	n/a	n/a
26	POLR2A	chr3:46940093-46940270	MCF-7	breast:	n/a	n/a
27	POLR2A	chr3:46941478-46941678	K562	blood:	n/a	n/a
28	POLR2A	chr3:46941932-46942850	K562	blood:	n/a	n/a
29	POLR2A	chr3:46940628-46940892	HUVEC	blood vessel:	n/a	n/a
30	POLR2A	chr3:46938433-46940961	K562	blood:	n/a	n/a
31	POLR2A	chr3:46941781-46941867	GM12878	blood:	n/a	n/a
32	RAD21	chr3:46940016-46940482	H1-hESC	embryonic stem cell:	n/a	n/a
33	RAD21	chr3:46940263-46940359	H1-hESC	embryonic stem cell:	n/a	n/a
34	REST	chr3:46941390-46941625	SK-N-SH	brain:	n/a	n/a
35	SIN3A	chr3:46940193-46940459	H1-hESC	embryonic stem cell:	n/a	n/a
36	SIN3A	chr3:46940758-46940777	H1-hESC	embryonic stem cell:	n/a	n/a
37	TCF12	chr3:46941330-46941760	ECC-1	luminal epithelium:	n/a	n/a
38	TCF12	chr3:46941288-46941879	ECC-1	luminal epithelium:	n/a	n/a
39	ZBTB7A	chr3:46941264-46941846	ECC-1	luminal epithelium:	n/a	n/a
40	ZNF143	chr3:46940194-46940303	H1-hESC	embryonic stem cell:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:46940153-46940203	HNPCEpiC	eye:	n/a
2	chr3:46940153-46940203	LNCaP	prostate:	n/a
3	chr3:46940347-46940397	ECC-1	luminal epithelium:	n/a
4	chr3:46940439-46940489	GM12892	blood:	n/a
5	chr3:46940212-46940262	AG04450	lung:	fetal
6	chr3:46940347-46940397	LNCaP	prostate:	n/a
7	chr3:46940347-46940397	HCF	heart:	n/a
8	chr3:46940347-46940397	T-47D	breast:	n/a
9	chr3:46940153-46940203	Hepatocyte	liver:	n/a
10	chr3:46940212-46940262	RPTEC	kidney:	n/a
11	chr3:46940212-46940262	NH-A	brain:	n/a
12	chr3:46940212-46940262	HAEpiC	amniotic membrane:	n/a
13	chr3:46942522-46942572	HRPEpiC	eye:	n/a
14	chr3:46940212-46940262	HEEpiC	esophagus:	n/a
15	chr3:46940439-46940489	HCF	heart:	n/a
16	chr3:46940153-46940203	RPTEC	kidney:	n/a
17	chr3:46940212-46940262	HCF	heart:	n/a
18	chr3:46940153-46940203	BJ	skin:	n/a
19	chr3:46942522-46942572	HAEpiC	amniotic membrane:	n/a
20	chr3:46940153-46940203	HRPEpiC	eye:	n/a
21	chr3:46940212-46940262	ovcar-3	ovarian:	n/a
22	chr3:46940439-46940489	HRE	kidney:	n/a
23	chr3:46940153-46940203	GM12878	blood:	n/a
24	chr3:46939978-46940028	A549	lung:	n/a
25	chr3:46942522-46942572	HepG2	liver:	n/a
26	chr3:46942522-46942572	SK-N-SH_RA	brain:	n/a
27	chr3:46940347-46940397	AG09319	gingival:	n/a
28	chr3:46940153-46940203	A549	lung:	n/a
29	chr3:46940347-46940397	MCF10A-Er-Src	breast:	n/a
30	chr3:46942522-46942572	MCF10A-Er-Src	breast:	n/a
31	chr3:46939978-46940028	NH-A	brain:	n/a
32	chr3:46940212-46940262	ProgFib	skin:	n/a
33	chr3:46940153-46940203	NHDF-neo	bronchial:	n/a
34	chr3:46940153-46940203	HepG2	liver:	n/a
35	chr3:46940439-46940489	ECC-1	luminal epithelium:	n/a
36	chr3:46940439-46940489	SAEC	small airway:	n/a
37	chr3:46940347-46940397	ovcar-3	ovarian:	n/a
38	chr3:46940153-46940203	AG04450	lung:	fetal
39	chr3:46939978-46940028	IMR90	lung:	fetal
40	chr3:46939978-46940028	HRE	kidney:	n/a
41	chr3:46940347-46940397	BE2_C	brain:	n/a
42	chr3:46940439-46940489	GM19239	blood:	n/a
43	chr3:46940153-46940203	GM12891	blood:	n/a
44	chr3:46940153-46940203	NB4	blood:	n/a
45	chr3:46940347-46940397	Hela-S3	cervix:	n/a
46	chr3:46940212-46940262	HRCEpiC	kidney:	n/a
47	chr3:46940212-46940262	PFSK-1	brain:	n/a
48	chr3:46940153-46940203	T-47D	breast:	n/a
49	chr3:46940439-46940489	BJ	skin:	n/a
50	chr3:46940347-46940397	AG10803	skin:	n/a

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:46940978..46942499-chr3:47420565..47422731,2	MCF-7	breast:
2	chr3:46858188..46860125-chr3:46939783..46942119,2	K562	blood:
3	chr3:46933982..46936274-chr3:46938142..46940231,2	MCF-7	breast:
4	chr3:46924894..46926955-chr3:46938452..46941314,2	K562	blood:
5	chr3:46929548..46935187-chr3:46936132..46940432,7	K562	blood:
6	chr3:46939682..46941906-chr3:46942383..46946161,3	K562	blood:
7	chr3:46936336..46938331-chr3:46941122..46942918,3	K562	blood:
8	chr3:46939682..46941423-chr3:46942383..46944944,2	K562	blood:
9	chr3:46940802..46943210-chr3:46954167..46956344,2	K562	blood:
10	chr3:46935290..46938710-chr3:46938764..46942918,5	K562	blood:

No data

Variant related genes	Relation type
PTH1R	TF binding region
PTH1R	CpG island
ENSG00000076201	chromatin interactions
ENSG00000260236	chromatin interactions
ENSG00000160801	chromatin interactions
ENSG00000268537	chromatin interactions

Extended variants
information (count: 114 )
Associated
traits (count: 103 )

Variant overlapped rSNPs/rCNVs (count:114 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs377622047	chr3:46940001-46940002	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs549353111	chr3:46940055-46940056	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs550566389	chr3:46940065-46940066	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs200796992	chr3:46940102-46940103	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs201769387	chr3:46940119-46940120	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs200157274	chr3:46940130-46940131	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs368282769	chr3:46940138-46940139	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs200920464	chr3:46940145-46940146	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs201490454	chr3:46940158-46940159	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs200817639	chr3:46940175-46940176	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs121434597	chr3:46940181-46940182	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs387907456	chr3:46940191-46940192	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs200073957	chr3:46940230-46940231	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs547682383	chr3:46940262-46940263	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs201016660	chr3:46940284-46940285	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs201880398	chr3:46940296-46940297	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs387907462	chr3:46940318-46940319	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs200224936	chr3:46940322-46940323	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs138060601	chr3:46940326-46940327	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs536442743	chr3:46940478-46940479	Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs555270840	chr3:46940516-46940517	Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs374582277	chr3:46940520-46940521	Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs576645811	chr3:46940534-46940535	Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs201918844	chr3:46940564-46940565	Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs375880193	chr3:46940571-46940572	Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Strong transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs555011284	chr3:46940640-46940641	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Genic enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs558964541	chr3:46940654-46940655	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Genic enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs577419212	chr3:46940680-46940681	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Genic enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs568989577	chr3:46940697-46940698	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Genic enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs41290650	chr3:46940750-46940751	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Enhancers Genic enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs559583997	chr3:46940816-46940817	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs201499957	chr3:46940820-46940821	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs371454798	chr3:46940828-46940829	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs387907459	chr3:46940833-46940834	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs200475872	chr3:46940834-46940835	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs202059785	chr3:46940841-46940842	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs200636306	chr3:46940859-46940860	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs374853100	chr3:46940886-46940887	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs201291962	chr3:46940950-46940951	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs373323204	chr3:46940954-46940955	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs140651831	chr3:46940962-46940963	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs570456160	chr3:46940976-46940977	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs200369682	chr3:46940985-46940986	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs201419242	chr3:46940991-46940992	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs2242116	chr3:46941116-46941117	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
46	rs561273977	chr3:46941170-46941171	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs150464988	chr3:46941178-46941179	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs549367218	chr3:46941199-46941200	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs558292040	chr3:46941245-46941246	Weak transcription Bivalent Enhancer Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs574862267	chr3:46941271-46941272	Weak transcription Bivalent Enhancer Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:103)

Disease	PMID	Source
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
Glioblastoma multiforme	21080181	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17133270	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Melanoma	20688739	CNVD
Acute myeloid leukemia	21251322	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Kartagener syndrome	16639409	CNVD
Biliary cancer	19435499	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Breast cancer	21509527	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	16397240	CNVD
Breast cancer	22032731	CNVD
Non-small cell lung cancer	20864512	CNVD
Colorectal cancer	16912164	CNVD
Non-small cell lung cancer	19010865	CNVD
Colorectal cancer	16272173	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Acute myeloid leukemia	17268525	CNVD
Salivary gland tumor	18059337	CNVD
Gastric cancer	16891809	CNVD
Night blindness	17160897	CNVD
Cancer	17160897	CNVD
Breast cancer	20409316	CNVD
Lung cancer	17297452	CNVD
Multiple myeloma	16616336	CNVD
Effusion lymphoma	18079361	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Neuroblastoma	20406844	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Urothelial cell carcinoma	18451213	CNVD
Neuroblastoma	17327916	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Melanoma	17363583	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Adrenocortical carcinoma	18281524	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:190 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:46934400-46940000	Weak transcription	Pancreas	Pancrea
2	chr3:46934400-46951000	Weak transcription	Psoas Muscle	Psoas
3	chr3:46934600-46949400	Weak transcription	Fetal Kidney	kidney
4	chr3:46934800-46940000	Weak transcription	Placenta Amnion	Placenta Amnion
5	chr3:46934800-46940200	Weak transcription	HUVEC	blood vessel
6	chr3:46935000-46940000	Weak transcription	Gastric	stomach
7	chr3:46935000-46940000	Weak transcription	Ovary	ovary
8	chr3:46935400-46940000	Weak transcription	Right Atrium	heart
9	chr3:46935400-46940400	Weak transcription	Left Ventricle	heart
10	chr3:46938000-46940000	Genic enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
11	chr3:46939400-46940000	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr3:46939400-46940000	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
13	chr3:46939400-46940000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
14	chr3:46939400-46940000	Bivalent Enhancer	Fetal Muscle Leg	muscle
15	chr3:46939400-46940600	Bivalent Enhancer	Fetal Intestine Small	intestine
16	chr3:46939400-46940800	Bivalent Enhancer	Primary B cells from peripheral blood	blood
17	chr3:46939400-46941400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
18	chr3:46939400-46941600	Enhancers	Spleen	Spleen
19	chr3:46939600-46940000	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
20	chr3:46939600-46940000	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
21	chr3:46939600-46940000	Enhancers	Brain Inferior Temporal Lobe	brain
22	chr3:46939600-46940000	Enhancers	HSMMtube	muscle
23	chr3:46939600-46940200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
24	chr3:46939600-46940200	Bivalent Enhancer	Fetal Brain Male	brain
25	chr3:46939600-46940200	Bivalent Enhancer	Fetal Intestine Large	intestine
26	chr3:46939600-46940400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
27	chr3:46939600-46940600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
28	chr3:46939600-46940600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
29	chr3:46939600-46940800	Enhancers	Fetal Heart	heart
30	chr3:46939600-46941400	Bivalent Enhancer	Fetal Stomach	stomach
31	chr3:46939600-46941800	Enhancers	Fetal Lung	lung
32	chr3:46939600-46945000	Weak transcription	K562	blood
33	chr3:46939800-46940000	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
34	chr3:46939800-46940000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
35	chr3:46939800-46940000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
36	chr3:46939800-46940000	Enhancers	Brain Angular Gyrus	brain
37	chr3:46939800-46940000	Enhancers	Brain Anterior Caudate	brain
38	chr3:46939800-46940000	Flanking Active TSS	Brain Germinal Matrix	brain
39	chr3:46939800-46940000	Enhancers	Brain Hippocampus Middle	brain
40	chr3:46939800-46940000	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
41	chr3:46939800-46940000	Enhancers	Brain Substantia Nigra	brain
42	chr3:46939800-46940000	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
43	chr3:46939800-46940000	Bivalent/Poised TSS	Skeletal Muscle Female	skeletal muscle
44	chr3:46939800-46940000	Bivalent Enhancer	Stomach Smooth Muscle	stomach
45	chr3:46939800-46940000	Flanking Active TSS	HSMM	muscle
46	chr3:46939800-46940200	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
47	chr3:46939800-46940200	Enhancers	Esophagus	oesophagus
48	chr3:46939800-46940200	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain
49	chr3:46939800-46940400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
50	chr3:46939800-46940400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links